Stock screener

CELZ

Conviction 4FinancialsScan · Mon, Aug 10, 2026
CELZ$1.18-16.90%
ResistanceSupportVol 14
63 bars
Vol MA14 27.3M
May 11May 28Jun 16Jul 6Jul 23Aug 10
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)www.creativemedicaltechnology.com
Price1.18
Change-16.90%
Gap-8.45%
Rel volume0.00×
Avg volume19.18M
Avg $ vol21.82M
SMA 200.8469
SMA 501.39
SMA 2002.08
Price vs 50-15.35%
Price vs 200-43.15%
MA stackbearish
50/200 cross
Supertrendup · 0.8093
RSI (14)55
MACD hist0.10
MACD cross
Stoch %K / %D42 / 50
ADX (14)29
+DI / −DI46 / 16
RSI divergence
MACD divergenceBullish
ATR %+21.42%
ADR %13.63%
52w high5.59
52w low0.6542
From 52w high-78.89%
Above 52w low+80.37%
New 52w highNo
SqueezeOff
Bollinger width89.66%
%B0.94
Donchian pos42.42%
Donchian high1.94
Donchian low0.6200
AVWAP (52w high)1.69
vs AVWAP high-30.07%
AVWAP (52w low)1.27
vs AVWAP low-7.20%
OBV trendUp
Chaikin MF (20)-0.54
Today vs 20d0.00×
Avg vol (14d)27.3M
Avg vol (20d)19.18M
Avg $ vol (20d)21.82M
Market cap
RS 3m (vs SPY)-43.69%
RS 6m (vs SPY)-34.34%
RS line new highNo
Trend template1/8
Technical rank27.7
1 week+80.37%
1 month+29.37%
3 months-48.92%
6 months-38.86%
1 year-68.36%
YTD-40.10%
P/E-1.57
P/B1.09
P/S
P/FCF
EPS-2.52
Div yield
ROE-69.27%
ROA-63.93%
Debt/Eq0.59
Current12.91
EV/EBITDA-1.65
Gross margin63.43%
Net margin
Rev growth-45.45%
EPS growth-9.13%
Price target20.00
Target upside1298.60%
Analyst ratingBuy
Institutional2.68%
Ent. value10.07M
Revenue0
Net income-1.51M
Gross profit0
Free cash flow
IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
ExchangeNasdaq
Shares out3.7M
Employees4
ListedThu, Apr 30, 2009
Free float
Float %
Short interest
Days to cover
Short volume
Squeeze score
Next earnings
EPS forecast
Last EPS vs est
Last surprise
Setup gradeD
Conviction4 / 100
Pattern quality
Tech rank27.7 / 100
Group rank96 / 100 · Leading
Status laneNo active setup
Setup direction
Pattern family
Resistance3.61
Support0.7050
Days since event
Candle confirm
News sentiment

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in CELZ

All disclosures →
No recent disclosed trades by Congress in CELZ. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in CELZ

No recent insider (Form 4) filings in CELZ. Insiders must file within two business days of a trade.

SEC filings

EDGAR filings in CELZ · 8 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.